share_log

Bellerophon Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-507 Summit LLC(8.4%),Lepercq Capital Management LLC(8.4%), etc.

Bellerophon Therapeutics | SC 13G:超過5%持股股東披露文件-507 Summit LLC(8.4%),Lepercq Capital Management LLC(8.4%)等

SEC announcement ·  01/26 10:49
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息